Search
for
Sort by
Research 241–270 of 452
- Phytochemicals as emerging therapeutic agents for alopecia treatment
- Effect of Kuntai Capsule Combined with Nilestriol Tablets in the Treatment of Perimenopausal Syndrome and on Reproductive Hormones
- Answers to CME examination
- Rapid determination and quantification of hair-growth compounds in adulterated products by ultra HPLC coupled to quadrupole-orbitrap MS
- Medical Treatment of Alopecia
- Hair Changes due to Drugs
- Androgenetska alopecija u žena
- Alopecia Areata
- Implicações da toma crónica da Finasteride para a Alopécia Androgenética no Carcinoma da Próstata
- Severe Alopecia Complicating Systemic Sclerosis
- Nonscarring Alopecias
- Table of Contents
- Analysis of Female Pattern Hair loss
- Obsessive-compulsive disorder in dermatology
- Conventional and novel stem cell based therapies for androgenic alopecia
- Alopecia Areata
- Hypertrichosis and Hyperpigmentation in the Periocular Area Associated with Travoprost Treatment
- Promising therapies for treating and/or preventing androgenic alopecia.
- Lasers, lights, and compounds for hair loss in aesthetics
- Comprehensive HPLC and UPLC-MS/MS Analysis for the Multi-component Detection of Hair Growth Compounds in Consumer Health Products
- Repigmentation through Melanocyte Regeneration in Vitiligo
- Alopecia Universalis Successfully Treated With Adalimumab
- Alopecia Areata: An Autoimmune Disease of Multiple Players
- Application of Topical Immunotherapy in the Treatment of Alopecia Areata: A Review and Update
- Alopecia areata: Part 2: treatment.
- Eyelash Transplantation Using Leg Hair by Follicular Unit Extraction
- Eyebrow Regrowth in Patients with Frontal Fibrosing Alopecia Treated with Low-Dose Oral Minoxidil
- Development and validation of the Brigham Eyelash Tool for Alopecia (BELA): A measure of eyelash alopecia areata
- Upadacitinib for management of recalcitrant alopecia areata: A retrospective case series
- Setipiprant for Androgenetic Alopecia in Males: Results from a Randomized, Double-Blind, Placebo-Controlled Phase 2a Trial